Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Balic, M; Rapp, N; Stanzer, S; Lin, H; Strutz, J; Szkandera, J; Daidone, MG; Samonigg, H; Cote, RJ; Dandachi, N.
Novel immunofluorescence protocol for multimarker assessment of putative disseminating breast cancer stem cells.
Appl Immunohistochem Mol Morphol. 2011; 19(1):33-40
Doi: 10.1097/PAI.0b013e3181ebf4e8
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Führende Autor*innen der Med Uni Graz
- Balic Marija
- Co-Autor*innen der Med Uni Graz
- Dandachi Nadia
- Rapp Nadine
- Samonigg Hellmut
- Stanzer Stefanie
- Strutz Jasmin
- Szkandera Joanna
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Purpose: The phenotypical and functional variety of breast cancer cells is well recognized. This variety is evident in primary tumors and in disseminated tumor cells (DTCs) and solid metastases as shown for recognized prognostic factors, such as estrogen receptor, progesterone receptor, or human epidermal growth factor receptor 2/neu and also for cancer stem cell markers such as CD44, CD24, or aldehyde dehydrogenase (ALDH). For the development of new therapeutic strategies, the identification and characterization of disseminated breast cancer cells are needed. This requires the use of multiple antibodies (ie, cytokeratin, Her2/neu, ALDH1, CD44, and CD24) labeled with fluorochromes of different colors and spectral image analysis to separate different color spectra. Methods: We have focused here on putative breast cancer stem cell markers and evaluated the feasibility of triple and quadruple labeling of breast cancer cells. Using breast cancer cell lines we have developed a method optimized for multimarker analysis by employing novel DyLight Technology. Single marker immunofluorescence was performed in 6 replicates, and reproducible results had to be obtained before proceeding to multimarker immunofluorescence. Results: Three of the markers, CD44, ALDH1, and cytokeratin have been directly conjugated with DyLight dyes. CD24 could not be conjugated directly to the fluorescent dye. A labeled secondary antibody was used for visualization. Single and multimarker immunofluorescence gave consistent results throughout the replicates. Conclusions: This novel protocol will facilitate detection and phenotypical characterization of disseminated tumor cells. In addition, by adding additional markers, distinct subpopulations could be evaluated for the expression of particular therapeutic targets.
- Find related publications in this database (using NLM MeSH Indexing)
- Antibodies, Neoplasm - chemistry Antibodies, Neoplasm - immunology
- Breast Neoplasms - metabolism Breast Neoplasms - pathology
- Female -
- Fluorescent Antibody Technique, Indirect - methods Fluorescent Antibody Technique, Indirect - standards
- Hep G2 Cells -
- Humans -
- Neoplastic Stem Cells - immunology Neoplastic Stem Cells - metabolism
- Tumor Markers, Biological - immunology Tumor Markers, Biological - metabolism
- Find related publications in this database (Keywords)
- multimarker immunofluorescence
- disseminated tumor cells
- breast cancer stem cells
- CD44(+)
- CD24(-)
- ALDH1